Radioligand Therapy Precisely Attacks Cancer Cells, Reducing Side Effects
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Taipei Veterans General Hospital introduced Radioligand Therapy (RLT), achieving good results for a neuroendocrine tumor patient by precisely attacking cancer cells with fewer side effects, offering a new option for patients with limited efficacy from traditional treatments.